title: Combined chemo-radiation and hyperthermia for locally advanced soft tissue sarcoma: response and toxicity.
abstract: BACKGROUND
  Evaluation of the primary effects and acute adverse reactions of combined chemo-radiation and hyperthermia for patients with locally advanced soft tissue sarcoma.
  
  
  METHODS
  Eight patients with locally advanced soft tissue sarcoma underwent a combination of radiation therapy, continuous infusion of doxorubicin, and once weekly hyperthermia.
  
  
  RESULTS
  Complete response was obtained in 2 patients and partial response in 3. Level 4 skin reaction was developed in 4 patients who had superficially located tumour. Treatment interruption more than three days was required in only one patient who developed level 4 pharyngitis. Five patients developed grade 3 leukopenia, 2 had grade 4 leukopenia requiring administration of haematopoietic growth factor. Two patients developed radiation pneumonitis which required steroid medication. No symptomatic cardiotoxicity was observed. There was no acute morbidity during the treatment.
  
  
  CONCLUSIONS
  The intensive combination therapy provided good local responses or at least palliation for most of the patients entered without increasing treatment morbidity.
authors.affiliation: Department of Radiation Therapy and Oncology, International Medical Center, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Uno
authors.forename: J
authors.initials: J
authors.lastname: Itami
authors.forename: H
authors.initials: H
authors.lastname: Kato
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007262:Infusions, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D010166:Palliative Care; D017564:Radiation Pneumonitis / Q000209:etiology; D012509:Sarcoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D004317:Doxorubicin